felis 517
hominis29, 517 – 518
lifecycle 51 8, 519
meleagridis 517
morphology 518
occurrence 517
parvum29, 51 6, 517 – 518
pathogens 517
prevention 520
therapy 519
Ctenocephalides
canis608, 618
felisfelis 618
CTXelement 297
CulturemethodsseeBac-
terialculture;Fungalcul-
ture;Viralculture
Cuninghamellaspp.354,
367
seealsoMucormycoses
Curvulariaspp.354, 369
Cutaneousinfections
650 – 653
bacteria 651 – 652
dermatitis553, 61 2, 61 4,
652
exfoliativa 233
dermatomycoses355,
37 2–3 74
fungi 652
mucormycosis 368
parasites 652 – 653
viruses 650
seealsospecificinfections
Cutaneouslarvamigrans
(CLM)584, 602
clinicalmanifestations
602
diagnosis 60 2, 652
therapy 602
Cutaneousleishmaniosis
seeLeishmania(leishma-
nioses)
Cutaneoustest 356
CXCR(chemokinerecep-
tor) 140
Cyclophosphamide 140
Cyclophyllida 545
Cyclosporacayetanensis
(cyclosporosis) 515 – 516
clinicalmanifestation
515
diagnosis 504 – 50 5, 51 6,
639
stoolspecimenhand-
ling 621
lifecycle 515
morphology 515
occurrence 515
therapy 516
Cyclosporine 140
CyclosporosisseeCyclo-
sporacayetanensis(cyclo-
sporosis)
Cymevene 404
Cysticercosis560,
564 – 565
clinicalmanifestations
564 – 565
diagnosis 56 5,625, 653
muscleinfection 654
epidemiology 564
neurocysticercosis
564 – 565
ocular 56 4, 657
therapy 565
Cystitis 292
Cystopyelitis 292
Cytoadherence 529
Cytocidalinfection
392 – 393
Cytokines 77 – 8 3, 207
assay 134
inmalaria 528 – 529
Cytomegalovirus(CMV)
41 8, 423 – 424
clinicalpicture 423
diagnosis 423 – 424
hematopoieticsystem
648
liver 641
nervoussystem 645
respiratorytract 631 ,
632
epidemiology 424
pathogenesis 423
prevention 424
treatment 424
Cytopathiceffect(CPE) 1 5,
392, 407
Cytophilic 140
Cytoplasm 151
Cytoplasmicmembrane
15 1–1 52
membraneproteins
15 1–1 52
outermembranepro-
teins 155
Cytostatic 140
Cytotoxic 140
CytotoxicTcellsseeTcells
Cytotoxins 1 5, 282&D
Dalfopristin 194
Daneparticle 430
Dapsone 19 4, 533
Decayacceleratingfactor
(DAF) 89
Decontamination 35
Defensemechanisms8, 21 ,
22, 99 – 103
antibodies 100
avoidancestrategies
12 – 1 5, 102 – 103
defectsinimmunede-
fenses 24
IgE-mediateddefense
101
nonlyticT-cellresponses
100
nonspecific 21 – 23, 10 0,
40 0–4 01
perforin-dependentcy-
totoxicityinCD8+Tcells
100
specific23, 401 – 402
seealsoImmunity
Delayedtypehypersensi-
tivity(DTH) 98 – 99,
114 – 115 , 140
Deletion 179
Dendriticcells 140
Dengue 443 – 445
Denguehemorrhagicfever
(DHF) 444
Dengueshocksyndrome
(DSS) 444
Dentalcaries 1 59,243, 259
Dentalplaque 1 59, 243
Dermacentor 607
Dermatitis 61 2, 614
cercarial 553
diagnosis 652
exfoliativa 233
scalp 614
Dermatomycoses355,
37 2–3 74
clinicalpictures
37 3–3 74
diagnosis 37 4, 652
epidemiology 374
prevention 374
therapy 374
seealsoDermatophytes
Dermatophagoidesptero-
nyssinus 612
Dermatophytes 372 – 374
classification 373DermatophytesE 671All rights reserved. Usage subject to terms and conditions of licenseKayser, Medical Microbiology © 2005 Thieme
All rights reserved. Usage subject to terms and conditions of license.